Lipid Efficacy of the Extended Release Niacin/Laropiprant Combination in Patients With Cardiovascular Disease
Condition(s):Coronary Artery Disease; DyslipidemiasLast Updated:September 21, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):Coronary Artery Disease; DyslipidemiasLast Updated:September 21, 2023Terminated
Condition(s):Aortocoronary Saphenous Vein Bypass Graft Atherosclerosis; Intermediate Saphenous Vein Graft LesionsLast Updated:August 17, 2017Completed
Condition(s):Ischemic StrokeLast Updated:September 14, 2012Completed
Condition(s):Atherogenic Dyslipidemia; Obesity Associated DisorderLast Updated:January 24, 2024Completed
Condition(s):AtherosclerosisLast Updated:June 17, 2009Terminated
Condition(s):HIV Infections; Dyslipidemia; Endothelial DysfunctionLast Updated:December 18, 2012Completed
Condition(s):HypoalphalipoproteinemiaLast Updated:September 13, 2013Completed
Condition(s):Metabolic SyndromeLast Updated:May 6, 2008Completed
Condition(s):Hypercholesteremia; HyperlipidemiaLast Updated:February 16, 2017Completed
Condition(s):HIV-1 InfectionLast Updated:February 3, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.